These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14726104)

  • 1. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.
    Mueller XM
    Ann Thorac Surg; 2004 Jan; 77(1):354-62. PubMed ID: 14726104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
    Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing the immunosuppressive regimen in heart transplantation.
    Eisen H; Ross H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.
    Bush WW
    AACN Clin Issues; 1999 May; 10(2):253-69; quiz 304-6. PubMed ID: 10578712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppression for kidney transplant recipients: current strategies].
    Alberú J; Urrea EM
    Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunossupresive drugs in renal transplantation].
    Baczkowska T; Durlik M
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():99-120. PubMed ID: 15669207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression.
    Söderlund C; Rådegran G
    Transplant Rev (Orlando); 2015 Jul; 29(3):181-9. PubMed ID: 25812489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
    Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N
    Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current State of Immunosuppression: Past, Present, and Future.
    Karam S; Wali RK
    Crit Rev Eukaryot Gene Expr; 2015; 25(2):113-34. PubMed ID: 26080606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression: towards a logical approach in liver transplantation.
    Perry I; Neuberger J
    Clin Exp Immunol; 2005 Jan; 139(1):2-10. PubMed ID: 15606606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
    Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of immunosuppression: the art and the science.
    Mancini MC; Cush EM; Launius BK; Brown PA
    Crit Care Nurs Q; 2004; 27(1):61-4. PubMed ID: 14974524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive treatment].
    Niaudet P
    Nephrol Ther; 2011 Dec; 7(7):592-8. PubMed ID: 22118788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression and Heart Transplantation.
    Sutaria N; Sylvia L; DeNofrio D
    Handb Exp Pharmacol; 2022; 272():117-137. PubMed ID: 34671867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimization of immunosuppression: transplant immunology.
    Patel J; Kobashigawa JA
    Transpl Immunol; 2008 Nov; 20(1-2):48-54. PubMed ID: 18930138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic immunosuppression.
    Barshes NR; Goodpastor SE; Goss JA
    Front Biosci; 2004 Jan; 9():411-20. PubMed ID: 14766378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation signal inhibitors in cardiac transplantation.
    Gustafsson F; Ross HJ
    Curr Opin Cardiol; 2007 Mar; 22(2):111-6. PubMed ID: 17284989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
    Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
    Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.